173 related articles for article (PubMed ID: 30220536)
1. [How to evaluate BPH-related SBAUs in clinical practice and research?].
Descazeaud A; Robert G; de La Taille A
Prog Urol; 2018 Nov; 28(15):830-838. PubMed ID: 30220536
[TBL] [Abstract][Full Text] [Related]
2. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
[TBL] [Abstract][Full Text] [Related]
3. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
4. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
[TBL] [Abstract][Full Text] [Related]
5. [Initial assessment and follow-up of benign prostatic hyperplasia: systematic review of the literature by the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; de la Taille A;
Prog Urol; 2012 Jan; 22(1):1-6. PubMed ID: 22195998
[TBL] [Abstract][Full Text] [Related]
6. Benign prostatic hyperplasia: clinical manifestations and evaluation.
Santos Dias J
Tech Vasc Interv Radiol; 2012 Dec; 15(4):265-9. PubMed ID: 23244722
[TBL] [Abstract][Full Text] [Related]
7. [Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery].
de la Taille A; Robert G; Descazeaud A
Prog Urol; 2018 Nov; 28(15):813-820. PubMed ID: 30262261
[TBL] [Abstract][Full Text] [Related]
8. Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment.
Mobley D; Feibus A; Baum N
Postgrad Med; 2015 Apr; 127(3):301-7. PubMed ID: 25823641
[TBL] [Abstract][Full Text] [Related]
9. [Management of the bladder outlet obstruction associated with BPH in patients with special circumstances and/or complications].
Descazeaud A; Robert G; de La Taille A
Prog Urol; 2018 Nov; 28(15):868-874. PubMed ID: 30220535
[TBL] [Abstract][Full Text] [Related]
10. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
[TBL] [Abstract][Full Text] [Related]
11. A practical primary care approach to lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH-LUTS).
Rosenberg MT; Witt ES; Miner M; Barkin J
Can J Urol; 2014 Jun; 21 Suppl 2():12-24. PubMed ID: 24978629
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive ultrasound measurements in male patients with LUTS and benign prostatic obstruction: implication for diagnosis and treatment.
Presicce F; DE Nunzio C; Gacci M; Finazzi Agrò E; Tubaro A
Minerva Urol Nefrol; 2017 Jun; 69(3):220-233. PubMed ID: 27706123
[TBL] [Abstract][Full Text] [Related]
13. Management of Benign Prostatic Hyperplasia in Older Adults.
Woodard TJ; Manigault KR; McBurrows NN; Wray TL; Woodard LM
Consult Pharm; 2016; 31(8):412-24. PubMed ID: 27535076
[TBL] [Abstract][Full Text] [Related]
14. Management of symptomatic BPH in Italy: who is treated and how?
Tubaro A; Montanari E
Eur Urol; 1999; 36 Suppl 3():28-32. PubMed ID: 10559628
[TBL] [Abstract][Full Text] [Related]
15. [How to prevent LUTS due to BPH development and progression].
de la Taille A; Descazeaud A; Robert G
Prog Urol; 2018 Nov; 28(15):821-829. PubMed ID: 30262262
[TBL] [Abstract][Full Text] [Related]
16. Management of Benign Prostatic Hyperplasia.
Kim EH; Larson JA; Andriole GL
Annu Rev Med; 2016; 67():137-51. PubMed ID: 26331999
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based guidelines in lower urinary tract symptoms secondary to benign prostatic hyperplasia and variation in care.
Strope SA
Curr Opin Urol; 2018 May; 28(3):262-266. PubMed ID: 29601306
[TBL] [Abstract][Full Text] [Related]
19. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
Silva J; Silva CM; Cruz F
Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.
Chan CK; Yip SK; Wu IP; Li ML; Chan NH
BJU Int; 2012 Jun; 109(11):1690-6. PubMed ID: 21933332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
